. .
Bruker Daltonics
Bruker

Application of MALDI-TOF Mass Spectrometry in Screening and Diagnostic Research

Type: Application

Scientific Paper

Clinical Proteomics, Functional Genomics

Number: Technology

CPD0511

MALDI-TOF

Year Products

2005

ClinProt, GenoTools, GENOLINK

  Author
 

W. Pusch* and M. Kostrzewa Bruker Daltonik GmbH, Fahrenheitstraße 4, D-28359 Bremen, Germany and Permoserstraße 15, D-04318 Leipzig, Germany

  Reference
 

Current Pharmaceutical Design, 2005, Vol. 11, No. 20; 2577-2591

 

Abstract

 

During the last years, mass spectrometry has revolutionised protein biochemistry and has advanced to a

superior tool for the identification and detailed analysis of peptides and proteins. The high throughput allowed by some

mass spectrometry platforms has enabled the important step from analysis of individual proteins to proteomics.

Recently, an additional field of mass spectrometry applications has emerged - namely screening and diagnostic research.

In contrast to protein identification, screening applications have to detect analyte molecules of defined molecular weights

which can be calculated beforehand, for example by means of chemical structures. Here, the accuracy and sensitivity of

mass spectrometry has to be combined with the requirements of high-throughput analyses, in particular speed and

automation. These criteria are especially fulfilled by state of the art matrix-assisted laser desorption/ionisation time-offlight

mass spectrometry (MALDI-TOF MS) instruments. The first high throughput screening (HTS) application proved

to be genotyping of single nucleotide polymorphisms. The same principle was later applied for several quality control

issues, for example for oligonucleotides, peptide or compound libraries. This development has culminated in the screening

and profiling of complex biomarker patterns in clinical proteomics to detect a molecular fingerprint for specific diseases

in biological samples. Thus, mass spectrometry based methods are expected to enable a very early diagnosis of diseases

with minimally invasive methods of investigation. This type of high end screening application has the potential to

revolutionise the early diagnosis of many diseases.

Here, we give an overview of the application of mass spectrometry in the fields of screening and diagnostic research.

 

Related Products

 

GenoTools

 

Download

 

Register with us
In order to get access to all our multimedia specials, additional content and to subscribe to our informative Daltonics E-Dispatch newsletter, please register to our website.